Geminal bisphosphonates are a group of drugs of particular interest because of their ability to modify calcium metabolism. This effect results from a decrease in the solubility ofhydroxyapatite in vitro and by cell mediated mechanisms in vivo.' 2 In clinical treatment, bisphosphonates have been used to treat metastatic bone disease,3 hypercalcaemia due to malignancy,4 5 and Paget's disease. 6 At the cellular level, the mode of action is not fully understood, but it is known that one of the target cells is the osteoclast, towards which dichloromethylene bisphosphonate (clodronate), at least, is toxic.2 Clodronate is highly soluble in water and shows a strong affinity for calcified tissue. 7 In an attempt to clarify the pharmacological mechanisms operating, a number of experimental models have been used.8 It has been shown in an in vivo experiment that clodronate also has antiinflammatory properties. 9 Hydroxyapatite crystals have been found in the joint effusions of patients with rheumatoid arthritis,'0 and macrophages remove these crystals from the joint cavities." Macrophages, in general, are immunoregulatory and inflammatory cells, the latter function being characterised by their phagocytic capacity. Phagocytosis is the primordial function of neutrophil granulocytes and the two cell types comprise the host's phagocytes. They have been found in the peritoneal cell exudate of many laboratory animals.'2 The membrane stimulation of inflammatory phagocytes can be measured by chemiluminescence, that is, the light generated by the oxygen dependent microbicidal system. The chemiluminescence assay is a measure of the rate of liberation of reactive oxygen species by macrophages and granulocytes; these reactive oxygen species may contribute to tissue damage in inflammatory diseases.'3 Different pathways of light production can be identified: the myeloperoxide mediated reaction can be identified by stimulating cells with zymosan and using luminol as an intermediate; superoxide anion dependent chemiluminescence can be measured by stimulating cells with phorbol myristate acetate and augmenting the light output with lucigenin.'4 Neutrophil granulocytes in most animal species can be strongly activated through these two pathways, whereas monocytes and macrophages have little or no myeloperoxidase.
On the basis of the reports summarised above, we decided to investigate, by transmission electron microscopy, whether the simultaneous presence of clodronate with pure hydroxyapatite particles influences the phagocytosis of these by rat peritoneal macrophages in vivo. We also wanted to see whether, in this experimental system, there would be an effect on the liberation of reactive oxygen species by these cells, as measured by chemiluminescence.
Materials and methods

HYDROXYAPATITE AND CLODRONATE
Chemically pure, synthetically manufactured hydroxyapatite (British Charcoals and MacDonald) with a mean particle size of 5 ,tm was used.
Clodronate (Leiras Pharmaceuticals) was dissolved in calcium and magnesium free phosphate buffered saline (PBS), pH 7-2, at a working concentration of 2 mg/ml. A hydroxyapatite/ clodronate combination was prepared by allow-ing the two compounds to react in the ratio of 1 g hydroxyapatite to 28 for two minutes, at room temperature (both stains from LKB). Finally, the specimens were mounted on copper grids, sputtered with carbon and viewed with a Jeol JEM-1200 EX transmission electron microscope.
For each experiment at each time point a minimum of 50 fields was examined to assess cell morphology and phagocytosis.
MEASUREMENT OF CHEMILUMINESCENCE
The concentration of cells was adjusted to 1 x 107 cells per ml for the chemiluminescence experiments.
To test the activation of the superoxide anion pathway, 500 ,ul of cell suspension was placed in the reaction cuvette, followed by 200 RI lucigenin (I X 10-3 M, Sigma Chemicals) and 200 ,ul phorbol myristate acetate as stimulant (2 5 [ig/ml, Sigma Chemicals).
The resultant chemiluminescence was measured at 37°C in an LKB 1250 luminometer, recorded as millivolts and calculated per 1 x 106 cells. From the curves generated the maximum potential was recorded. In addition, the area under the curve was quantitated between the start of the experiment and the point at which the potential had declined to 50% of the peak value. This was achieved by digitising the data from the curves using a Kontron image analysis system (IBAS 1).
To assess any contribution to the production of chemiluminescence by the myeloperoxidase mediated pathway, 200 RI luminol (5 x 10-4 M) and 200 1t serum treated zymosan (10 mg/ml) were added to the reaction vial. The two chemiluminescence systems were studied alone and consecutively in the cell batch experiment. For example, luminol and zymosan were added to the reaction cuvette after the chemiluminescence produced by the lucigenin/ phorbol myristate acetate regimen had subsided to 50% of the peak potential and vice versa. At least one duplicate experiment was conducted on cells collected from each animal.
STATISTICAL ANALYSIS
Student's t test was used for statistical analysis.
Results
Cell viability in the lavage fluid was consistently greater than 96%, as determined by the trypan blue dye exclusion test.
TRANSMISSION ELECTRON MICROSCOPY EXPERIMENTS
Phagocytosis and morphology were assessed only for the macrophages. These made up approximately 90% of the exudate cells, the rest of the cells being mainly granulocytes. Effect of clodronate Initially, the cell morphology seemed to be unaffected by the presence of clodronate. Figure  2A shows that until 24 hours after injection the cells from the control and injected animals looked similar. Figure 2B shows that macrophages collected later showed increasing heterogeneity of the cytoplasm, but mitochondria were seen.
Phagocytosis of hydroxyapatite particles
After 12 hours of incubation there was evidence of intracellular hydroxyapatite, but at this time particles were also regularly observed extracellularly. All hydroxyapatite particles had been phagocytosed by 24 hours as none was seen extracellularly. Figure 3 shows that in several 72 and 96 hour specimens disintegration of intravacuolar hydroxyapatite particles was observed. This was accompanied by vacuolisation of the cytoplasm and degeneration of cellular morphology ( fig 3B) .
Phagocytosis of hydroxyapatite particles reacted with clodronate Phagocytosis was frequently seen from 12 hours onwards. By 24 hours most but not all hydroxyapatite particles were intracellular, and by 48 hours no particles remained outside the cells. Hydroxyapatite particle disintegration apd crystal dissolution were seen only rarely at 48 hours, but in numerous cells in 72 and 96 hour experiments (figs 4A and B). The frequency or extent of particle dissolution was not quantitated. In the presence of phagocytosis, good cell morphology was preserved during the incubation. Figure 4B shows that at 96 hours cytoplasm had degenerated less than in cells containing plain hydroxyapatite, and morphologically distinct mitochondria were seen. The situation was similar at 72 hours. Figure 4C shows an example of more advanced hydroxyapatite particle dissolution at 96 hours. Figure 5 shows a typical example of phorbol In addition to the results shown in the tables, there was a significant difference in both the potential and the area under the curve between 10 mg/kg clodronate and 10 mg/kg hydroxyapatite/clodronate (p<OO1).
Discussion
The mechanism(s) by which bisphosphonate drugs exert their therapeutic effects in the management of osteolytic bone diseases have been extensively studied, but only partly elucidated. It is now known that, in bone, the osteoclast is the primary biological target of clodronate. 2 15 In this study we have attempted to apply two methods of studying the effects of bisphosphonate on inflammatory cells. This approach was used to aid the understanding of the proposed anti-inflammatory action of clodronate9 at the cellular level. This drug has been studied extensively and used in treatment for many years and data have accumulated on its effect on hard tissue metastases,'6 17 hypercalcaemia due to malignancy,4 18 Paget's disease of bone,6 8 and osteoporosis.'9 This drug affects not only an effective means of entry into the cell, once the particle is phagocytosed. Its high solubility in water, which prevents it passing through physiological membranes and thus entering the cell in large amounts (only 1-2%, concluded from the kinetic study of Yakatan et al23), may facilitate its intracellular pharmacological action after having gained entry at a higher concentration in combination with the mineral. When hydroxyapatite particles were preincubated with clodronate, phagocytosis was observed less frequently at 12 and 24 hours than for hydroxyapatite particles alone. This finding is in agreement with the impaired attachment of macrophages to bone in the presence of bisphosphonate, observed by Chambers using light microscopy. 24 The hypothesis that the action of clodronate on the macrophage is mediated intracellularly is naturally valid, at least in the presence of hydroxyapatite. The observed delay in phagocytosis of the hydroxyapatite/clodronate particles may be a result of extracellular membrane irritation due to the clodronate bound to the crystal surface. Cellular toxicity has been shown towards the macrophage.' 24 
